Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hahn, HG | - |
dc.contributor.author | Oh, HS | - |
dc.contributor.author | Cheon, SH | - |
dc.contributor.author | Oak, MH | - |
dc.contributor.author | Kim, YR | - |
dc.contributor.author | Kim, KM | - |
dc.date.accessioned | 2024-01-21T07:07:26Z | - |
dc.date.available | 2024-01-21T07:07:26Z | - |
dc.date.created | 2021-09-02 | - |
dc.date.issued | 2004-05 | - |
dc.identifier.issn | 0253-6269 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/137616 | - |
dc.description.abstract | An allergic reaction ensues after antigen binds to mast cell or basophil high affinity IgE receptor, FcepsilonRI, resulting in degranulation of various inflammatory mediators that produce various allergic symptoms. In this study, i) we isolated the active component for the inhibition of mast cell degranulation from the extract of leaves of Castanea crenata and identified it as quercetin; ii) we established the total synthesis procedure of quercetin; iii) using quercetin as positive control, we excavated some lead compounds that possess inhibitory activities for mast cell degranulation by screening the chemical libraries of 1,3-oxazolidine derivatives prepared by solid phase combinatorial chemistry. Some of 1,3-oxazolidine compounds possessing acetyl and 3',4'-dichlorophenyl group displayed strong inhibitory activities on FcepsilonRI-mediated mast cell degranulation, suggesting that they can be used as lead compounds for the development of anti-allergic agents. | - |
dc.language | English | - |
dc.publisher | PHARMACEUTICAL SOC KOREA | - |
dc.subject | ANTIALLERGIC ACTIONS | - |
dc.subject | RECEPTOR | - |
dc.subject | ANTIGEN | - |
dc.subject | RELEASE | - |
dc.title | Excavation of lead compounds that inhibit mast cell degranulation by combinatorial chemistry and activity-guided | - |
dc.type | Article | - |
dc.identifier.doi | 10.1007/BF02980125 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | ARCHIVES OF PHARMACAL RESEARCH, v.27, no.5, pp.518 - 523 | - |
dc.citation.title | ARCHIVES OF PHARMACAL RESEARCH | - |
dc.citation.volume | 27 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 518 | - |
dc.citation.endPage | 523 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.identifier.kciid | ART000936172 | - |
dc.identifier.wosid | 000221753400009 | - |
dc.identifier.scopusid | 2-s2.0-16544365647 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | ANTIALLERGIC ACTIONS | - |
dc.subject.keywordPlus | RECEPTOR | - |
dc.subject.keywordPlus | ANTIGEN | - |
dc.subject.keywordPlus | RELEASE | - |
dc.subject.keywordAuthor | Castanea crenata | - |
dc.subject.keywordAuthor | quercetin | - |
dc.subject.keywordAuthor | mast cell degranulation | - |
dc.subject.keywordAuthor | combinatorial chemistry | - |
dc.subject.keywordAuthor | 1,3-oxazolidines | - |
dc.subject.keywordAuthor | allergy | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.